Scholars Central

Conference abstractPublished 15 Jun 2026

Cardiac Magnetic Resonance Imaging in the Assessment of Myocardial Fibrosis among Patients with Dilated Cardiomyopathy

Authors: Daniel Moreno

Department of Cardiovascular Medicine, University of Barcelona, Spain

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Myocardial fibrosis is an important predictor of adverse clinical outcomes in patients with dilated cardiomyopathy (DCM). Cardiac magnetic resonance imaging (CMR) with late gadolinium enhancement (LGE) provides a non-invasive and highly accurate approach for identifying fibrotic myocardial tissue and assessing disease severity. The ability of CMR to characterize myocardial tissue has transformed the diagnosis and management of cardiomyopathies by offering detailed structural and functional information. A prospective observational study involving 185 patients with confirmed DCM was conducted over a 24-month period. Participants underwent comprehensive CMR evaluation, including ventricular function assessment, late gadolinium enhancement imaging, and quantitative fibrosis analysis. The extent of myocardial fibrosis was correlated with left ventricular ejection fraction, ventricular remodeling, arrhythmia occurrence, hospitalization rates, and overall clinical outcomes. Follow-up examinations were performed to evaluate disease progression and therapeutic response. Patients demonstrating extensive late gadolinium enhancement experienced significantly higher rates of ventricular arrhythmias, reduced left ventricular systolic function, and an increased incidence of heart failure related hospitalizations. Quantitative fibrosis assessment provided additional prognostic value beyond conventional echocardiographic parameters, allowing more accurate identification of high-risk patients. Furthermore, CMR findings contributed to improved clinical decision-making regarding implantable cardioverter-defibrillator placement and optimization of medical therapy. These findings support the growing role of CMR as an indispensable imaging modality for risk stratification, personalized treatment planning, and long-term monitoring of patients with dilated cardiomyopathy. Incorporating advanced CMR techniques into routine clinical practice may improve patient outcomes through earlier diagnosis and more targeted therapeutic interventions.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Daniel Moreno”